GBM Awareness Day is July 17. Join us in raising awareness all month long! Learn more.
A Dose Escalation and Expansion Study of Sonodynamic Therapy With SONALA-001 in Combination With Exablate 4000 Type-2 MR-guided Focused Ultrasound in Patients With Recurrent or Progressive Glioblastoma Multiforme
Category (Adult, Pediatric):
AdultLocation:
TexasPhase:
1/2Sponsor:
SonALAsenseDescription:
The primary goal of this trial is to evaluate the safety and preliminary efficacy of sonodynamic therapy (SDT) using intravenous SONALA-001 combined with Exablate Type-2 MRI-guided focused ultrasound in patients with recurrent or progressive glioblastoma.Last updated March 27, 2023
